Clincosm LogoSign in Get a demo

Influenza

Showing NaN - NaN of 60
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Influenza, Influenza Immunization Trial in United States (Influenza Hemagglutinin mRNA vaccine, Quadrivalent Recombinant

Completed
  • Influenza
  • Influenza Immunization
  • Influenza Hemagglutinin mRNA vaccine
  • Quadrivalent Recombinant Influenza Vaccine
  • Rolling Hills Estates, California
  • +19 more
Oct 31, 2023

SARS-CoV-2, Influenza Trial in Canada, United States (mRNA-1083, Placebo, Influenza Vaccine)

Not yet recruiting
  • SARS-CoV-2
  • Influenza
  • mRNA-1083
  • +3 more
  • Anniston, Alabama
  • +172 more
Oct 18, 2023

SARS-CoV-2, Influenza Trial in United States (Fluarix, mRNA-1083.1, mRNA-1083.2)

Recruiting
  • SARS-CoV-2
  • Influenza
  • Fluarix
  • +8 more
  • Chandler, Arizona
  • +68 more
Apr 24, 2023

Influenza Trial in Worldwide (Baloxavir Marboxil, Placebo)

Recruiting
  • Influenza
  • Baloxavir Marboxil
  • Placebo
  • Birmingham, Alabama
  • +290 more
Jan 20, 2023

SARS-CoV-2, Influenza Trial in United States (mRNA-1073, mRNA-1010, mRNA-1273)

Active, not recruiting
  • SARS-CoV-2
  • Influenza
  • mRNA-1073
  • +3 more
  • Hollywood, Florida
  • +13 more
Oct 5, 2022

Influenza Trial in United States (FluBlok®, Placebo)

Completed
Has Results
  • Influenza
  • FluBlok®
  • Placebo
  • Beverly Hills, California
  • +23 more
Mar 24, 2022

Influenza, Human, Virus Diseases Trial in United States (QIVc, Comparator QIV)

Completed
Has Results
  • Influenza
  • +2 more
  • QIVc
  • Comparator QIV
  • Mobile, Alabama
  • +46 more
Dec 13, 2021

Influenza Type A, Influenza Type B, Influenza Trial in Austin (SAB-176, Normal Saline)

Active, not recruiting
  • Influenza Type A
  • +2 more
  • SAB-176
  • Normal Saline
  • Austin, Texas
    PPD, Phase 1 Clinic
Oct 25, 2021

Influenza Trial in Worldwide (Liquid CAIV-T)

Completed
  • Influenza
  • Liquid CAIV-T
  • Hoover, Alabama
  • +160 more
Sep 10, 2021

Influenza Trial in United States (Instramuscular vaccine)

Active, not recruiting
  • Influenza
  • Instramuscular vaccine
  • Huntsville, Alabama
  • +13 more
Apr 22, 2021

Influenza Trial in Finland, Poland, United States (Cell culture-derived influenza vaccine, Egg-derived influenza virus vaccine,

Completed
Has Results
  • Influenza
  • Cell culture-derived influenza vaccine
  • +2 more
  • Denver, Colorado
  • +55 more
Aug 2, 2019

FLU A+B Nasal Swab Clinical Study

Completed
  • Influenza
  • Non-invasive diagnostic testing
  • Chicago, Illinois
  • +4 more
Mar 25, 2019

Influenza Trial in United States (GSK investigational vaccine GSK1557482A, Fluzone®)

Completed
Has Results
  • Influenza
  • GSK investigational vaccine GSK1557482A
  • Fluzone®
  • Birmingham, Alabama
  • +27 more
Aug 22, 2018

Influenza Trial in Mexico, United States (FluLaval™ Quadrivalent, Fluzone® Quadrivalent)

Completed
Has Results
  • Influenza
  • FluLaval™ Quadrivalent
  • Fluzone® Quadrivalent
  • Birmingham, Alabama
  • +65 more
Aug 9, 2018

Influenza Trial in Canada, United States (GSK2340274A, GSK2340273A, Seasonal trivalent influenza vaccine (TIV))

Completed
Has Results
  • Influenza
  • GSK2340274A
  • +3 more
  • Stockbridge, Georgia
  • +6 more
Jul 4, 2018

Influenza Trial in Worldwide (Fluarix, Fluzone)

Completed
Has Results
  • Influenza
  • Fluarix
  • Fluzone
  • Birmingham, Alabama
  • +68 more
Jul 2, 2018

Influenza Trial in Canada, United States (A/turkey H5N1 vaccine, Influenza A (H5N1) Virus Monovalent Vaccine, Adjuvanted

Completed
Has Results
  • Influenza
  • A/turkey H5N1 vaccine
  • +2 more
  • Denver, Colorado
  • +12 more
Jun 8, 2018

Influenza Trial in Canada, United States (Investigational H9N2 vaccine GSK2654911A, Investigational H9N2 vaccine GSK2654909A,

Completed
  • Influenza
  • Investigational H9N2 vaccine GSK2654911A
  • +2 more
  • Miami, Florida
  • +3 more
Jun 14, 2018

Influenza Trial in United States (Fluarix™, Fluzone)

Completed
Has Results
  • Influenza
  • Fluarix™
  • Fluzone
  • Antioch, California
  • +39 more
May 8, 2018

Influenza Trial in Canada, United States (Influenza A (H5N1) Virus Monovalent Vaccine, Adjuvanted, Placebo)

Completed
Has Results
  • Influenza
  • Influenza A (H5N1) Virus Monovalent Vaccine, Adjuvanted
  • Placebo
  • Huntsville, Alabama
  • +39 more
May 9, 2018

Influenza Trial in United States (CSL Limited Influenza Virus Vaccine (Afluria®), US Licensed Influenza Virus Vaccine

Completed
Has Results
  • Influenza
  • CSL Limited Influenza Virus Vaccine (Afluria®)
  • US Licensed Influenza Virus Vaccine (Fluzone®)
  • Mountain Home, Arkansas
  • +12 more
Apr 25, 2018

Influenza Trial in United States (CSL's 2009 H1N1 Influenza Vaccine (CSL425), Placebo)

Completed
Has Results
  • Influenza
  • CSL's 2009 H1N1 Influenza Vaccine (CSL425)
  • Placebo
  • Chandler, Arizona
  • +12 more
Apr 25, 2018

Influenza Trial in Australia, Puerto Rico, United States (Nitazoxanide, Placebo)

Completed
  • Influenza
  • Hot Springs, Arkansas
  • +27 more
Apr 2, 2018

Influenza Trial in Worldwide (Nitazoxanide, Oseltamivir, Placebo Oral Tablet)

Completed
  • Influenza
  • Birmingham, Alabama
  • +166 more
Mar 27, 2018

Influenza Trial in Canada, United States (GSK2340274A, GSK2340273A)

Completed
Has Results
  • Influenza
  • GSK2340274A
  • GSK2340273A
  • Conway, Arkansas
  • +29 more
Nov 10, 2017